Yamane, N
(This analysis does not include all GLP-1s covered by Medicare, only those products with more recent FDA approvals that are also approved as weight loss medications.) Spending on Ozempic alone increased substantially between 2021 and 2022
The pooled estimates may be underestimates of the efficacy of newer agents, although the review could not determine whether stronger weight-loss effects necessarily translate into greater reductions in binge eating
BOOK A CONSULTATION WITH AN EXPERIENCED AUSTRALIAN DOCTOR TODAY TO DISCUSS YOUR HAIR AND SCALP CONCERNS: CLICK HERE REFERENCES: Hamblin PS, Earnest A, Russell AW, Talic S, Zomer E, Zoungas S
& Li, Z
From a therapeutic perspective, GLP-1 receptor agonists drugs that mimic the endogenous hormone GLP-1 are used to treat type 2 diabetes and obesity by improving insulin secretion, lowering blood sugar, and supporting weight reduction